Liposomal Formulations in Clinical Use: An Updated Review.
Bulbake U, Doppalapudi S, Kommineni N, Khan W. · 2017
Read Liposomal Formulations in Clinical Use: An Updated Review. by Bulbake U, Doppalapudi S, Kommineni N, Khan W. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5489929.txt.
Description
Bulbake and co-authors present an updated review in Pharmaceutics on liposomal drug products in clinical use. Liposomes are tiny spheres of fat-like membrane that carry drugs inside. Wrapping a drug in them changes where it travels in the body. That shift can raise benefit and cut side effects. Liposomes were the first nano delivery system to reach patients.
The review details the platform methods behind approved products. Stealth coatings and DepoFoam slow-release systems both feature. Marketed items such as Doxil and Ambisome are described in turn. Cancer drugs dominate the list, with fungal drugs and vaccines also covered. Ongoing clinical trials close the survey.
Catalog record
| CREATOR | Bulbake U, Doppalapudi S, Kommineni N, Khan W. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 112 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |